June 2023, Vol 4, No 2

Dr Tim F. Greten discussed emerging targets for the treatment of cholangiocarcinoma coming from translational research studies.
Read More

Dr Mark O’Hara discussed the growing potential of CAR T-cell therapy in cholangiocarcinoma.
Read More

Dr Sandra J. Casak discussed future thinking regarding clinical trials in cholangiocarcinoma, including a “seamless” oncology drug development paradigm.
Read More

Page 2 of 2


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: